📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Systemic silencing of PHD2 causes reversible immune regulatory dysfunction. (2019)

First Author: Yamamoto A

Attributed to: Therapeutic targeting of HIF prolyl hydroxylases in acute myeloid leukaemia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1172/jci124099

PubMed Identifier: 31162141

Publication URI: http://europepmc.org/abstract/MED/31162141

Type: Journal Article/Review

Volume: 129

Parent Publication: The Journal of clinical investigation

Issue: 9

ISSN: 0021-9738